Dimerization of human immunodeficiency virus type 1 reverse transcriptase. A target for chemotherapeutic intervention.
Open accessThe DOI matches its Crossref record.
Abstract
Recombinant human immunodeficiency virus type 1 reverse transcriptase has been used to investigate the process of dimer formation and the properties of the different mono- and dimeric forms of the enzyme. The studies show that reverse transcriptase activity is exclusively confined to the dimeric forms. As we also demonstrate, the association rate constant between the monomers is relatively low so that the dimer-monomer equilibrium is very slowly established. This offers a new and potentially interesting target for antiviral chemotherapy with presumably higher specificity than the currently used nucleoside analogs (Yarchoan, R., Mitsuya, H., Myers, C.E., and Broder, S. (1989) N. Eng. J. Med. 321, 726-738), which in their active triphosphorylated form are also inhibitors of cellular polymerases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 14
- Bradford, 1976, Anal. Biochem., 72, 248, 10.1016/0003-2697(76)90527-3 · DOI · Paper page
- DiMarzo-Veronese, 1986, Science, 231, 1289, 10.1126/science.2418504 · DOI · Paper page
- Hizi, 1977, J. Biol. Chem., 252, 2281, 10.1016/S0021-9258(17)40552-7 · DOI · Paper page
- Hizi, 1977, J. Biol. Chem., 252, 2290, 10.1016/S0021-9258(17)40553-9 · DOI
- Lightfoote, 1986, J. Virol., 60, 771, 10.1128/jvi.60.2.771-775.1986 · DOI · Paper page
- Lowe, 1988, Biochemistry, 27, 8884, 10.1021/bi00425a002 · DOI · Paper page
- Müller, 1989, J. Biol. Chem., 264, 13975, 10.1016/S0021-9258(18)71628-1 · DOI
- Prasad, 1989, J. Biol. Chem., 264, 16689, 10.1016/S0021-9258(19)84760-9 · DOI
- Schatz, 1989, FEBS Lett., 257, 311, 10.1016/0014-5793(89)81559-5 · DOI · Paper page
- Soltis, 1988, Proc. Natl. Acad. Sci. U. S. A., 85, 3372, 10.1073/pnas.85.10.3372 · DOI
- Starnes, 1988, J. Biol. Chem., 263, 5132, 10.1016/S0021-9258(18)60689-1 · DOI
- Tisdale, 1988, J. Virol., 62, 3662, 10.1128/jvi.62.10.3662-3667.1988 · DOI
- Wray, 1981, Anal. Biochem., 118, 197, 10.1016/0003-2697(81)90179-2 · DOI · Paper page
- Yarchoan, 1989, N. Engl. J. Med., 321, 726, 10.1056/NEJM198909143211106 · DOI · Paper page
Cited by
Wang, J., Smerdon, S. J., Jäger, J., Kohlstaedt, L. A., Rice, P. A., Friedman, J. M., & Steitz, T. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7242 · Cited by 175
Gopalakrishnan, V, Peliska, J. A., & Benkovic, S. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10763 · Cited by 175
RNase H activity of HIV reverse transcriptases is confined exclusively to the dimeric forms
Restle, T., Müller, B., & Goody, R. S. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80172-d · Cited by 68
Self-citationCamarasa, M.-J., Velázquez, S., San-Félix, A., Pérez-Pérez, M.-J., & Gago, F. (2006) · Antiviral Research · doi:10.1016/j.antiviral.2006.05.021 · Cited by 66
Effects of efavirenz binding on the subunit equilibria of HIV-1 reverse transcriptase
Venezia, C. F., Howard, K. J., Ignatov, M. E., Holladay, L. A., & Barkley, M. D. (2006) · Biochemistry · doi:10.1021/bi051915z · Cited by 59
Metadata
- Authors
- Restle, T., Müller, B., & Goody, R. S.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1990-06
- Volume
- 265
- Issue
- 16
- Pages
- 8986-8988
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1497536572
- Cited by
- 184
- References
- 0
- FWCI
- 16.37
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 11099 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dimerization of human immunodeficiency virus type 1 reverse transcriptase. A target for chemotherapeutic intervention. https://app.cochat.ai/papers/10.1016/s0021-9258(19)38799-x
- The paper
- Restle, T., Müller, B., & Goody, R. S. (1990). Dimerization of human immunodeficiency virus type 1 reverse transcriptase. A target for chemotherapeutic intervention. Journal of Biological Chemistry. https://doi.org/10.1016/s0021-9258(19)38799-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.